/
/
/

Zydus Lifesciences Balance Sheet

Consolidated
Standalone
₹
%

Share Price Live Stats

Open (₹)1,200.00
Volume (₹)23.10 L
High (₹)1,204.90
Upper Circuit1,231.80
Low (₹)1,172.00
Lower Circuit1,160.20
Prev Close1,188.10
52W High (₹)1,266.60
Price1,193.00
52W Low (₹)835.50

Share Market Cap & Key Ratios Overview

M.Cap (₹)118703.00 Cr
Div. Yield (%)0.08
PE Ratio28.40
Debt to Equity0.43
Price to Book3.23
Book Value269.50
EPS (TTM)41.90
Face Value1.00
ROE (%)19.69

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
LAURUSLABSNSE
ZYDUSLIFENSE
DRREDDYNSE
CIPLANSE
MANKINDNSE
AUROPHARMANSE
LUPINNSE
LTP
1W Low
1W High
Market cap (₹)
1829+51.3 (2.89%)
1722
1839.70
4,26,122Cr
10140.5+360.5 (3.69%)
9863
10159
2,66,424Cr
4710+96.6 (2.09%)
4553
4753.40
1,79,914Cr
2346-59.5 (-2.47%)
2252.40
2441.90
1,24,601Cr
1193-52.5 (-4.22%)
1172
1266.60
1,18,703Cr
1366+14 (1.04%)
1336.70
1384
1,14,599Cr
1404.1+25.2 (1.83%)
1364.60
1408
1,13,112Cr
2518+25.2 (1.01%)
2457.90
2561.20
1,04,631Cr
1785+103.6 (6.16%)
1656.20
1796.80
97,878Cr
1988-23 (-1.14%)
1944.10
2062.10
92,145Cr

Key Highlights of Zydus Lifesciences Ltd Balance Sheet

Zydus Lifesciences Ltd balance sheet discloses shareholders' funds of ₹100.6Cr as of 2026-03-31. The company’s equity share capital is at a value of ₹100.6Cr, and the reserves and surplus of the company is ₹23571.1Cr.

The company has its non-current liabilities with total liabilities of ₹39011Cr as of 2026-03-31.

The current liabilities are ₹7883.1Cr as of 2026-03-31. At the same time, current assets are ₹18542.3Cr as of 2026-03-31.

Key assets on the balance sheet are non-current investments of ₹7273.1Cr and tangible assets of ₹5083.9Cr, provided in the Zydus Lifesciences Ltd financial statements.